Stay updated with breaking news from Melissab Epperly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wedbush lowered shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an outperform rating to a neutral rating in a research note released on Wednesday, MarketBeat reports. They currently have $12.00 price objective on the stock, down from their previous price objective of $38.00. Wedbush also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its target price reduced by HC Wainwright from $55.00 to $46.00 in a report published on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Zentalis Pharmaceuticals’ Q4 2023 earnings at ($0.83) EPS, FY2023 earnings at ($4.44) EPS, […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) shares dropped 4.1% on Monday . The company traded as low as $17.22 and last traded at $17.22. Approximately 162,213 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 709,252 shares. The stock had previously closed at $17.95. Analysts Set […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded down 3.2% on Monday . The stock traded as low as $18.21 and last traded at $18.34. 146,579 shares were traded during trading, a decline of 79% from the average session volume of 706,325 shares. The stock had previously closed at $18.94. Wall Street […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have been given an average rating of “Buy” by the eleven research firms that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have updated their coverage on […]